Johnson & Johnson seek approval for COVID-19 vaccine in Japan
U.S. health care conglomerate Johnson & Johnson said on Monday it had sought regulatory approval for its one-shot COVID-19 vaccine in Japan and could begin delivering doses to the country in early 2022, a once approval is given.
The health ministry gave final approval for the emergency use of two COVID-19 vaccines – developed by Moderna and AstraZeneca respectively – on Friday in hopes of giving the developed world’s slowest vaccine rollout a boost on Friday. much needed injection in the arm.
Previously, Japan had only approved the coronavirus vaccine produced by US drug maker Pfizer.
Tokyo’s fast-track approvals of the three vaccines came despite the lack of large-scale clinical trials in Japan, as the lower number of COVID-19 cases compared to other countries made it difficult to obtain candidates for the vaccine. ‘trial. Moderna and AstraZeneca vaccine approvals over four months overdue on UK approval
The Johnson & Johnson shot has fueled controversy, having been linked to a rare disease involving blood clots.
In a time of both disinformation and too much information, quality journalism is more crucial than ever.
By subscribing you can help us make the right story.
Disclaimer! Toysmatrix is an automatic aggregator around global media. All content is available free on the Internet. We just organized it on one platform for educational purposes only. In each content, the hyperlink to the main source is specified. All trademarks are the property of their rightful owners, all materials are the property of their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by E-mail – [email protected]. Content will be removed within 24 hours.